GSA CAPITAL PARTNERS LLP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 113 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q1 2023$1,178
+70.2%
133,396
+47.2%
0.12%
+36.0%
Q4 2022$692
-99.7%
90,603
+215.7%
0.09%
+218.5%
Q3 2022$204,000
+4.1%
28,702
+18.4%
0.03%
-6.9%
Q2 2022$196,000
-6.7%
24,245
+223.9%
0.03%
+11.5%
Q4 2021$210,000
-27.6%
7,485
+24.8%
0.03%
-18.8%
Q2 2019$290,0006,0000.03%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2019
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 17,332,191$535,565,00013.21%
TIGER MANAGEMENT L.L.C. 1,115,411$34,466,00013.06%
VIKING GLOBAL INVESTORS LP 38,406,607$1,186,764,0006.18%
Senator Investment Group LP 5,113,085$146,145,0003.67%
Casdin Capital, LLC 463,125$14,310,562,0001.48%
Graticule Asia Macro Advisors LLC 356,326$11,010,0000.86%
Ratan Capital Management LP 41,272$1,275,0000.67%
Rock Springs Capital Management LP 545,000$16,841,0000.67%
MYDA Advisors LLC 34,000$1,051,0000.48%
Aristotle Atlantic Partners, LLC 50,459$1,559,0000.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders